PMID: 9194127Jun 1, 1997Paper

Monte Carlo and analytical calculation of proton pencil beams for computerized treatment plan optimization

Physics in Medicine and Biology
A K CarlssonA Brahme

Abstract

Proton pencil beams in water, in a format suitable for treatment planning algorithms and covering the radiotherapy energy range (50-250 MeV), have been calculated using a modified version of the Monte Carlo code PTRAN. A simple analytical model has also been developed for calculating proton broad-beam dose distributions which is in excellent agreement with the Monte Carlo calculations. Radial dose distributions are also calculated analytically and narrow proton pencil-beam dose distributions derived. The physical approximations in the Monte Carlo code and in the analytical model together with their limitations are discussed. Examples showing the use of the calculated set of proton pencil beams as input to an existing photon treatment planning algorithm based on biological optimization are given for fully 3D scanned proton pencil beams; these include intensity modulated beams with range shift and scanning in the transversal plane.

References

Mar 1, 1992·Medical Physics·A AhnesjöA Trepp
Jul 1, 1991·Physics in Medicine and Biology·P Andreo
Jan 1, 1991·Medical Physics·A S Shiu, K R Hogstrom
Oct 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A AgrenI Turesson
Mar 1, 1990·Medical Physics·D J Simpkin, T R Mackie
Mar 1, 1989·Physics in Medicine and Biology·K R HogstromG Starkschall
Jun 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A BrahmeB K Lind
Jan 1, 1988·Physics in Medicine and Biology·T R MackieJ J Battista
Jan 1, 1986·Medical Physics·R MohanL Lidofsky
Mar 1, 1985·Medical Physics·T R MackieJ J Battista
Jan 1, 1981·Acta Radiologica. Oncology·A BrahmeP Andreo
Jan 1, 1982·Acta Radiologica. Oncology·A Brahme
May 1, 1981·Physics in Medicine and Biology·K R HogstromP R Almond
May 1, 1995·Medical Physics·D W RogersT R Mackie
Jun 1, 1995·Physics in Medicine and Biology·K R RussellA Montelius
Mar 1, 1994·Medical Physics·A GustafssonA Brahme
Sep 1, 1995·Physics in Medicine and Biology·T KnöösL Weber
Aug 1, 1996·Physics in Medicine and Biology·L HongM Urie
Aug 1, 1996·Physics in Medicine and Biology·T Bortfeld, W Schlegel

❮ Previous
Next ❯

Citations

Sep 30, 2000·Medical Physics·G A Sandison, A V Chvetsov
Aug 9, 2003·Medical Physics·H Paganetti, B Gottschalk
Sep 21, 2004·Medical Physics·Matthias Fippel, Martin Soukup
Dec 17, 2010·Medical Physics·David JetteWeimin Chen
Feb 16, 2006·Medical Physics·George CiangaruAlfred R Smith
Sep 6, 2014·Journal of Medical Physics·Keyvan Jabbari, Jan Seuntjens
Jan 24, 2012·Zeitschrift für medizinische Physik·Julia StröbeleDietmar Georg
Apr 15, 2014·International Journal of Radiation Oncology, Biology, Physics·Clemens GrassbergerHarald Paganetti
Apr 24, 2004·Zeitschrift für medizinische Physik·Simeon NillUwe Oelfke
Nov 2, 2015·Medical Physics·Regina RescignoDavid Brasse
May 16, 2007·Medical Physics·D PflugfelderU Oelfke
Mar 8, 2003·Technology in Cancer Research & Treatment·Lech PapiezVadim Moskvin
Jun 19, 2003·Physics in Medicine and Biology·Ryosuke KohnoHiroyuki Matsuda
Jun 25, 2004·Physics in Medicine and Biology·Irena GudowskaAnders Brahme
Aug 8, 2002·Physics in Medicine and Biology·C Yeboah, G A Sandison
Oct 12, 2002·Physics in Medicine and Biology·Hanitra Szymanowski, Uwe Oelfke
Sep 21, 2006·Physics in Medicine and Biology·Nobuyuki KanematsuHaruo Yamashita
Jul 20, 2007·Physics in Medicine and Biology·Wayne NewhauserRadhe Mohan
Mar 27, 2009·Physics in Medicine and Biology·A StankovskiyL Demarzi
Nov 21, 2009·Physics in Medicine and Biology·George CiangaruMichael T Gillin
Oct 21, 2005·Physics in Medicine and Biology·Martin SoukupMarkus Alber
Mar 23, 2006·Physics in Medicine and Biology·T AkagiM Abe
Mar 9, 2012·Physics in Medicine and Biology·E SeravalliF Verhaegen
Apr 19, 2003·Physics in Medicine and Biology·Hanitra Szymanowski, Uwe Oelfke
Aug 15, 2008·Physics in Medicine and Biology·Harald PaganettiMartijn Engelsman
Mar 11, 1999·Physics in Medicine and Biology·A Lomax
Feb 10, 2021·Healthcare·Güler Burcu SenirkentliAlok Mishra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.